In a report published yesterday in Cancer Cell journal, American researchers are focusing on gene mutations found in a third of brain gliomas.

On Wednesday 9th December the All Party Parliamentary Group (APPG) on Brain Tumours held a meeting in Westminster to discuss the new five year Independent Cancer Taskforce Strategy. The event was well attended and several MPs came along to listen to the experiences and concerns of our supporters.

Two new NHS proton beam centres have commenced construction with planners claiming they could treat 1,500 patients a year.

Deadly viruses are being combined with a cancer cell killing virus in trials aimed at destroying glioma brain tumours.

Our survey looking at quality of life issues in children, young people and families has been extended to ensure our findings have the biggest possible impact, we’d like closer to 500.

Tributes have been paid to The Brain Tumour Charity’s ‘sassy and brave’ Young Ambassador Tasha Floyd, who has died at the age of 24.

We were recently pleased to hear that the National Institute for Health and Care Excellence (NICE) will be developing a new guideline on primary brain tumours and cerebral metastases.

We’re aiming to tackle the issue of late diagnosis of brain tumours. For this to happen we’ve enlisted the support of researchers, GPs and our community, to drive awareness and effect change to diagnosis times. Spearheading this Christmas Campaign is Sophie O’Hagan.

Ewan MacKerracher, a ten year old boy from Coleraine, Northern Ireland, has been diagnosed twice in the past with brain tumours. He has been waiting almost two years for a routine scan that could show any recurrence of the disease.

China joins GBM AGILE, an Australasian adaptive clinical trial project tackling glioblastoma multiforme.

From Call of Duty to Candy Crush, digital games are played by millions around the world. But could they offer more than entertainment?

Scientists from the Translational Genomics Research Institute have identified the drug propentofylline (PPF) that limits the protein TROY in glioblastoma (GBM) cells and that also increases the effectiveness of chemotherapy drug temozolomide and radiation to treat GBM.

“Keep going because I promise you, you will succeed. Any dream you have, just smash it.”

In July 2015 Alice was discharged after nine years of treatment and monitoring for a brain tumour. Her mum Emma talks about what it means to get to the end of treatment.

A research team based in Catalonia, Spain, has pioneered a more accurate and less invasive liquid biopsy technique for brain tumours.

Australian researchers, coordinating with teams from Germany, have trialled genetically-modified algae loaded with chemotherapy drugs and found that they destroy 90% of cancer cells while leaving healthy ones intact.

We would like to invite you to our meeting of the All-Party Parliamentary Group (APPG) on Brain Tumours.

Brain tumour patients are more likely to be diagnosed via a hospital A&E department than those with any other type of tumour, new figures show.

Claiming to be a world’s first, Canadian scientists have used targeted ultrasound and microbubbles to deliver chemotherapy drugs directly into brain tumours.

The Off-patent Drugs Bill has been blocked at its second reading in the House of Commons despite support from MPs of both parties and a number of charities and health organisations. It will be put onto the agenda for another reading in December, however is unlikely to be allocated time for debate.

The American Brain Tumour Association (ABTA), founded in 1973 and based in Chicago, has announced it is awarding $1million in new research grants.

Scientists have discovered a protein that is produced inside the blood vessels at the invasive edge of brain tumours.

One of our fantastic Young Ambassadors April Watkins recently met with Caroline Lucas, the country’s first Green Party MP in Brighton, where she was able to share details of our HeadSmart campaign and her personal experiences as a young adult going through treatment for a brain tumour.

The potential benefit of the Off-patent Drugs Bill to people affected by a brain tumour has been highlighted in an editorial featured in The Telegraph. The paper also features a letter in support of The Bill signed by 40 clinicians including Professor Susan Short who is leading a clinical trial to investigate the effect of hydroxychloroquine on high grade gliomas undergoing radiotherapy.